Are your patients ready to embrace change?

Article

Happy New Year to you all. I'm sure, by now, the memories of Christmas have faded and the New Year's resolutions have already been broken but I do hope you used the holiday season to recharge your batteries, ready to face whatever 2007 may bring.

We kick off this year with a special focus on the ageing eye - presbyopia. As with all surgical procedures, we highlight the importance of patient communication here. Indeed, some specialists believe that effective communication could yield a practice with a near 100% patient satisfaction record. We have tried our best to cover this diverse and complex area of research, but I'm sure that the best is yet to come. As the year unfolds, I imagine we will be seeing the treatment of presbyopia evolve significantly as the pace of research and development looks set to step up a gear.

Going back to the subject of communication, I was talking with my grandmother over the Christmas break about her progress since she had undergone cataract surgery two months earlier. Now, I admit that English is not her first language and my spoken Greek is far from perfect but, with the help of my trusted translator (my Mother), I asked her how she felt following her surgery. She said that she felt fine but didn't understand why her vision was now blurred with her current prescription of spectacles. When I asked her to remove her spectacles and look at the television, I asked her if she could see better. She confirmed that she could but she insisted on keeping her spectacles on as she was afraid of "developing a headache".

I'd like to thank you for joining us at the beginning of what I'm sure will be another great year.

Fedra Pavlou Editorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.